Kristina Wang

Kristina Wang leads strategy and business development at Apertura. Prior to Apertura, Ms. Wang invested in early-stage life sciences companies at a healthcare venture capital firm, F-Prime Capital Partners, and worked on business development and strategy at Denali Therapeutics. She received her MMSc in Immunology from Harvard Medical School and MBA from Harvard Business School. In graduate school, she worked on engineering gene regulatory elements for gene therapy applications in the lab of Mike Greenberg and spun out the technology into Apertura.